Kanao-Kanda Megumi, Kanda Hirotsugu, Takahata Osamu, Kunisawa Takayuki
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Ther Clin Risk Manag. 2016 Jun 9;12:927-9. doi: 10.2147/TCRM.S107350. eCollection 2016.
Gabapentin, an anticonvulsant agent, is now often used for the treatment of neuropathic pain all over the world. It is unclear whether the combined use of gabapentin, sodium valproate, and flunitrazepam results in enhancement of the side effect, a gait disturbance. A 60-year-old man was taking oral sodium valproate for symptomatic epilepsy after a brain contusion and flunitrazepam to relieve insomnia. Oral gabapentin therapy was started for suspected neuropathic pain. Although the initial dose of oral gabapentin (200 mg) relieved the pain, the lower extremities became weak, resulting in a gait disturbance. The therapy was restarted with a halved dose, and this resolved the gait disturbance and relieved the pain.
加巴喷丁是一种抗惊厥药物,目前在全球范围内常用于治疗神经性疼痛。加巴喷丁、丙戊酸钠和氟硝西泮联合使用是否会增强副作用(步态障碍)尚不清楚。一名60岁男性因脑挫伤后出现症状性癫痫而口服丙戊酸钠,并服用氟硝西泮以缓解失眠。因怀疑患有神经性疼痛开始口服加巴喷丁治疗。尽管口服加巴喷丁的初始剂量(200毫克)缓解了疼痛,但下肢变得无力,导致步态障碍。治疗以减半剂量重新开始,这解决了步态障碍并缓解了疼痛。